* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 58
cents per share for the quarter ended in September. The lone
analyst forecast for the quarter was for a loss of 73 cents per
share.
* Revenue rose 33.6% to $1.43 million from a year ago;
analysts
expected $1.40 million.
* InspireMD Inc's reported EPS for the quarter was a loss
of 58
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* InspireMD Inc shares had fallen by 27.1% this quarter and
lost 64.2% so far this year.
* The company reported a quarterly loss of $4.53 million.
* Wall Street's median 12-month price target for InspireMD
Inc is
$5.60
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 02:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.73 -0.58 Beat
Jun. 30 2022 -0.73 -0.59 Beat
Mar. 31 2022 -0.80 -0.57 Beat
Dec. 31 2021 -0.78 -0.53 Beat